Rheumatoid Arthritis Unknown Status Phase 4 Trials for Iguratimod (DB12233)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02275299Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid ArthritisTreatment
NCT01893151Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRITreatment